Tag: PierianDx

RELEASE: PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution

PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today a partnership with Cancer Genetics, Inc. (CGI) (Nasdaq: CGIX) to provide a comprehensive precision oncology testing and workflow solution to enhance patient care. CGI is a leader in enabling precision medicine for oncology through molecular markers and diagnostics. The partnership combines CGI’s Focus::NGS® offering, a suite of next generation sequencing (NGS) tests providing a comprehensive view of the […]